Global Healthcare Data Monetization Market Size & Trends Report Segmented by Type (Direct, Indirect), Deployment Type (On-premise, Cloud-based), End-user (Pharma & Biotech Companies, Healthcare Providers & Payers, Med-tech Companies) & Regional Forecast to 2030

The global healthcare data monetization market is expected to grow at a CAGR of ~15% during the forecast period. Rising demand for real-world evidence (RWE), increasing adoption of electronic health records (EHR) & digital health platforms, growing volume of large & complex healthcare datasets, the increasing focus on personalized medicine supported by AI & predictive analytics, and investments in telehealth & remote monitoring startups are some of the key driving factors supporting market growth. However, strict data privacy concerns and lack of interoperability & data standardization remain major restraints impacting the growth of the global healthcare data monetization market. To learn more about the research report, download a sample report.

Overview

Healthcare data monetization refers to the practice of using healthcare data to improve services and operations internally or to sell information to external organizations in order to create monetary or other economic benefits. As healthcare environments grow digitally, they generate vast amount of data from multiple sources such as telemedicine platforms, genomics, electronic health records (EHRs), wearable devices, imaging, and medical billing systems. This data can be aggregated, anonymized, and utilized for multiple secondary purposes outside of direct patient care. Healthcare data monetization turns unprocessed, unused data into valuable intelligence that drives innovation, enhances results, and facilitates new revenue streams across the healthcare ecosystem.

To learn more about this report, download the PDF brochure

Growing importance of real-world evidence in healthcare data monetization

A major factor driving the healthcare data monetization market is the rising demand for real world evidence (RWE). RWE is derived from clinical practice data, wearables, insurance claims, tele-health applications, and electronic health records (EHRs). RWE has significantly transformed the approach of pharma and biotech companies towards drug discovery, regulatory approvals, and post-market surveillance. The ongoing shift from volume-based to value-based, which complements RWE as both aim towards cost-effectiveness and an outcome-based approach in therapeutics.

With the rising incidence of chronic diseases like cancer and diabetes, RWE plays a crucial role in long-term patient monitoring. Moreover, the shift towards personalized medicines requires vast datasets to tailor treatments. This demand has further encouraged pharmaceuticals and med-tech companies to market anonymized data sets for use in pharmaceutical research, diagnostics, and AI-powered clinical decision-making.

AI-powered insights drive the next phase of healthcare monetization

The healthcare data monetization market is witnessing a shift towards AI-driven tools that provide real-time data insights instead of just raw and unstructured ERP data. These tools are integrated with predictive analytics, which gives precise cohort analysis and a comprehensive patient summary. These services are provided through cloud-based platforms and APIs. Pharmaceutical companies, payers, and researchers hence gain valuable insights through an application programming interface or software as a service with safe, on-demand access, while healthcare organizations that commercialize data intelligence enhance both their revenue potential and strategic significance in the digital healthcare ecosystem.

To learn more about this report, download the PDF brochure

Recent developments in the healthcare data monetization market

Recent developments in the healthcare data monetization landscape highlight a shift toward secure, collaborative, and AI-driven ecosystems that enhance data sharing and unlock greater value across the sector, enabling healthcare and life sciences organizations to gain deeper insights from real-world data while safeguarding patient privacy. For instance,

• In December 2024, Atropos Health announced the launch of AI model training capabilities on the Atropos Evidence Network, the largest federated healthcare data network with over 300 million patient records, which has enabled life sciences organizations, including pharmaceutical companies, to build, test, train, and deploy AI models to identify overlooked patient populations
• In October 2024, datma, Inc. launches datma.FED, an innovative two-sided marketplace designed to enhance the sharing, accessibility, and monetization of healthcare data, by connecting data custodians (like health system and reference labs) with pharmaceutical and research organizations

Competitive Landscape Analysis

The global healthcare data monetization market comprises of several well-established and emerging players, including Oracle Corporation; SAS Institute Inc.; Salesforce, Inc.; Particle Health, Inc.; SAP SE.; Microsoft Corporation; Komodo Health, Inc.; Snowflake Inc.; ThoughtSpot Inc.; and Tibco Software, among others. Key strategies adopted by these players include the development of advanced platforms, mergers and acquisitions, and investment in R&D to enhance healthcare data monetization and meet growing global demand.

Report Scope

Growth Rate

Report Metric	Details
Base Year Considered	2024
Historical Data	2023 - 2024
Forecast Period	2025 - 2030
~15%
Market Drivers	Increasing adoption of EHRs and digital health platforms Expansion of large, complex and unstructured healthcare datasets Acceleration of personalized medicine initiatives leveraging patient-level data AI and predictive analytics integration improving healthcare insights and outcomes Increasing investment in telehealth and remote monitoring startups
Attractive Opportunities	Rising adoption of subscription-based and on-demand analytics dashboards Commercialization of anonymized datasets for pharma and AI-based research Partnerships between tech firms and healthcare providers for data-driven solutions Emergence of blockchain for secure healthcare data exchange and tracking
Segment Scope	Type, Deployment Type, and End-user
Regional Scope	North America (US & Canada) Europe (UK, Germany, France, Italy, Spain, Rest of Europe) Asia Pacific (China, India, Japan, Rest of Asia Pacific) Latin America Middle East & Africa
Key Companies Mapped	Oracle Corporation; SAS Institute Inc.; Salesforce, Inc; Particle Health, Inc.; SAP SE; Microsoft Corporation; Komodo Health, Inc.; Snowflake Inc.; Exactech, Inc.; and Tibco Software; among others
Report Highlights	Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis

������

Global Healthcare Data Monetization Market Segmentation

This report by Medi-Tech Insights provides the������size of the global healthcare data monetization market at the������regional- and country-level from 2023 to 2030. The report further segments the market based on type, deployment type, and end-user.

Market Size & Forecast (2023-2030), By Type, USD Million

• Direct Data Monetization
• Indirect Data Monetization

Market Size & Forecast (2023-2030), By Deployment Type, USD Million

• On-Premises
• Cloud-based

Market Size & Forecast (2023-2030), By End-user, USD Million

• Pharma & Biotech Companies
• Healthcare Providers
• Healthcare Payers
• Med-tech Companies
• Others

M; Forecast (2023-2030), By Region, USD Million

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East & Africa

Key Strategic Questions Addressed

• What is the market size & forecast of the healthcare data monetization market?
• What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the healthcare data monetization market?
• What are the key trends defining the market?
• What are the major factors impacting the market?
• What are the opportunities prevailing in the market?
• Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
• Who are the major players operating in the market?
• What are the key strategies adopted by players?